Amazon's encroachment into healthcare advanced a little further this week when the online giant launched a doctor consultation service delivered via its Alexa voice assistant, with the help
Amazon’s Alexa device can already field health and medical questions, but the library of responses has now been bulked up thanks to a partnership with digital health company Sharecare.
Voice technology like Amazon’s Alexa is taking some big steps forward in healthcare and in the pharmaceutical world one of the companies working in this area is Eisai.
Over the last two years Amazon’s healthcare plans have gone from being a closely guarded secret to underpinning a series of very public deals and product launches, with 2018 proving to be t
Amazon’s healthcare ambitions for Alexa took a big step forward this month with the announcement that its smart speaker can now handle health information compliantly.
Eli Lilly has added $1 billion to its investment plan for a new manufacturing facility in Ireland that will be used to produce its Alzheimer's therapy donanemab.
The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance the use of GenAI in life sciences R&D, seeking through pinpo